Minimal immunogenic potential: Long-term studies in rodents and primates report no antibody formation, suggesting a low risk of immune reactions following repeated exposure to the peptide
Finer than 27 gauge should not be used, because of the danger of it breaking whilst in your flesh
10.1186/s40478-019-0737-z Acta Neuropathol
Twenty-four hours later, ALT increased to 1562 U/L, AST 1466 U/L, ALP 334 U/L, and total bilirubin 1.6 mg/dL, with disproportionate elevation of aminotransferases consistent with the hepatocellular pattern of injury
Heres what they found: Compared to usual care, GLP-1RA use was associated with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions